CordovaCann (LVRLF) Amortization - Intangibles (2019 - 2020)
CordovaCann (LVRLF) recorded quarterly Amortization - Intangibles of $7822.9 in Q2 2020, down 62.1% quarter-over-quarter from $20638.9 in Q1 2020, and up 237.38% on a YoY basis from $2318.7 in Q3 2019.
CordovaCann (LVRLF) Amortization - Intangibles (2019 - 2020) Analysis & Trends
CordovaCann's Amortization - Intangibles history runs 2 years deep, the most recent figure standing at $7822.9 for Q2 2020.
- In Q2 2020, Amortization - Intangibles rose 237.38% year-over-year to $7822.9; the TTM figure through Jun 2020 stood at $69104.6 (changed N/A YoY), while the FY2025 annual figure was $299136.6, down 17.62% from the prior year.
- Amortization - Intangibles was $7822.9 for Q2 2020 at CordovaCann, down from $20638.9 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $22986.3 in Q4 2019 to a low of -$5694.5 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | CordovaCann | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 7,822.90 |
| Mar 31, 2020 | 20,638.90 |
| Dec 31, 2019 | 22,986.29 |
| Sep 30, 2019 | 17,656.53 |
| Jun 30, 2019 | -5,694.45 |